Zymeworks, Inc. (ZYME)
23.55
-0.40
(-1.67%)
USD |
NASDAQ |
Jan 22, 16:00
23.54
-0.01
(-0.04%)
After-Hours: 20:00
Zymeworks Research and Development Expense (TTM): 142.83M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Jazz Pharmaceuticals Plc | 809.33M |
| Johnson & Johnson | 14.70B |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Vertex Pharmaceuticals, Inc. | 3.954B |
| CorMedix, Inc. | 12.46M |